EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of MED-CANNABIS PHARMA, INC. (the “Company”) on Form 10-Q/A for the period ended June 30, 2015 as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Dated:  August 14, 2015

/s/ Gracie Moreno

Name: Gracie Moreno

Title: Chief Executive Officer, President, Principal Executive Officer and Director

Dated:  August 14, 2015

/s/ Garrett Vogel

Name: Garrett Vogel

Title:    CFO, Principal Accounting Officer, Treasurer, and Secretary